[go: up one dir, main page]

HK40061312B - 用於治疗与过度血管化相关的眼部疾病的化合物 - Google Patents

用於治疗与过度血管化相关的眼部疾病的化合物 Download PDF

Info

Publication number
HK40061312B
HK40061312B HK62022050642.7A HK62022050642A HK40061312B HK 40061312 B HK40061312 B HK 40061312B HK 62022050642 A HK62022050642 A HK 62022050642A HK 40061312 B HK40061312 B HK 40061312B
Authority
HK
Hong Kong
Prior art keywords
composition
eye
neovascularisation
use according
treatment
Prior art date
Application number
HK62022050642.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK40061312A (zh
Inventor
Helena ERIKSSON
Joel Kaye
Marie TÖRNGREN
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Publication of HK40061312A publication Critical patent/HK40061312A/zh
Publication of HK40061312B publication Critical patent/HK40061312B/zh

Links

HK62022050642.7A 2019-12-19 2020-12-18 用於治疗与过度血管化相关的眼部疾病的化合物 HK40061312B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19218062.8 2019-12-19
EP20156158.6 2020-02-07

Publications (2)

Publication Number Publication Date
HK40061312A HK40061312A (zh) 2022-05-27
HK40061312B true HK40061312B (zh) 2023-01-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP3886858B1 (en) Compounds for treatment of eye diseases associated with excessive vascularisation
WO2010125416A1 (en) Drug delivery to the anterior and posterior segments of the eye
CN111372598A (zh) 使用消除衰老细胞的药剂治疗诸如黄斑变性,青光眼,和糖尿病性视网膜病变等眼科状况
AU2017223838A1 (en) Treatment of neurodegenerative eye disease using pridopidine
CN109996814A (zh) 多激酶抑制剂及在眼部纤维化中的用途
US12102640B2 (en) Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration
US20070027102A1 (en) Methods and compositions for treating macular degeneration
Marquezan et al. Effect of topical tacrolimus in the treatment of Thygeson's superficial punctate keratitis
IL262526A (en) Diptididyl peptidease 4 inhibitors for topical treatment of neurodegenerative retinal diseases
EP4257148A1 (en) Eyedrops for treating scleral thinning and screening method for therapeutic agent of scleral thinning
Chen et al. Vitamin K1 alleviates retinal inflammation following acute ocular hypertension by modulating microglial ferroptosis
HK40061312B (zh) 用於治疗与过度血管化相关的眼部疾病的化合物
HK40061312A (zh) 用於治疗与过度血管化相关的眼部疾病的化合物
Tao et al. Intravitreous delivery of Αb-crystallin ameliorates N-methyl-N-nitrosourea induced photoreceptor degeneration in mice: an in vivo and ex vivo study
EA045318B1 (ru) Соединения для лечения глазных болезней, связанных с избыточной васкуляризацией
CN114099487B (zh) 乙醇胺在制备预防、缓解和/或治疗神经炎症相关疾病的产品中的应用
EP4640702A1 (en) Use of alpha-2,6-sialylated immunoglobulin in preventing or treating dry eye syndrome or inflammatory eye diseases
Narayanaswamy et al. Randomized, controlled trial of a sustained delivery formulation of 5-fluorouracil for the treatment of failing blebs
Ghule et al. Intravitreal Bevacizumab (Avastin) Alone Or With Laser Photocoagulation for Diabetic Macular Edema
Rocha-de-Lossada et al. Toxicidade do depatuxizumabe mafodotina (ABT-414) na superfície ocular: relatos de casos
Ferrer et al. Ophthalmic therapeutics: new basic research and clinical studies
Abelson et al. New treatments may improve dry eye care.
EA043539B1 (ru) Фармацевтическая комбинация и ее применение в способе лечения офтальмологических заболеваний
JP2017165674A (ja) アフリベルセプトによる網膜保護作用